New EANM award supports alpha radioligand therapy research
View as a Web Page
News Medical
 
  Prostate Cancer Prostate Cancer logo  
  The latest prostate cancer news from News Medical  
 Serial liquid biopsies reveal evolution in advanced prostate cancerSerial liquid biopsies reveal evolution in advanced prostate cancer
 
A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that androgen receptor (AR) alterations consistently emerged and were linked to poorer outcomes across therapies.
 
 
 New EANM award supports alpha radioligand therapy researchNew EANM award supports alpha radioligand therapy research
 
Applications are now open for the 2026 EANM Young Scientist Network Award. This new research award, supported by Advanced Accelerator Applications (a Novartis company), aims to accelerate innovative research in alpha radioligand therapy (α-RLT) in prostate cancer.
 
 Democrats decry meager medical care for detainees in funding fight
 
Democrats decry meager medical care for detainees in funding fightFernando Viera Reyes needed a biopsy for possible prostate cancer when the Trump administration sent him to an immigration detention center in California's Mojave Desert.
 
 
 Combination therapy may help overcome barrier in early-stage prostate cancer treatment
 
A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026